
Podcast
Ardena CEO on Navigating CDMO Volatility: Specialization, Nanomedicine, and Resilience
“Despite the volatility, the industry is getting some positive energy and renewed confidence” Jeremie Trochu, Chief Executive Officer at Ardena, has spent two decades building and scaling businesses across the biopharma sector. He was part of the leadership team that